JY Research Institute Inc

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Gout2 trials
• Alzheimer disease1 trial
• Fatty liver disease (MASLD/MASH)1 trial

Phase

• Phase 2/32 trials
• Phase 32 trials

Status

• Active, not recruiting1 trial
• Completed1 trial
• Recruiting1 trial
• Terminated1 trial

Lead sponsor

• Atom Therapeutics Co., Ltd2 trials
• Inventiva Pharma1 trial
• Karuna Therapeutics, Inc., a Bristol Myers Squibb company1 trial

Running trials

• Recruiting

  Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

  NCT05980949· Phase 3· Karuna Therapeutics, Inc., a Bristol Myers Squibb company· Source

  Contact: Suez Oramas Mingo, Site 1138

• Active, not recruiting

  A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )

  NCT04849728· Phase 3· Inventiva Pharma· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Alzheimer disease1 recruiting

Closed trials

• Terminated

  Extension Study of ABP-671 in Participants With Gout

  NCT06276556· Phase 2/3· Atom Therapeutics Co., Ltd· Source

• Completed

  Phase 2b/3 Study to Assess ABP-671 a Novel URAT1 Inhibitor in Participants With Gout

  NCT05818085· Phase 2/3· Atom Therapeutics Co., Ltd· Source